Apnimed, Inc. (APMD) vs Jade Biosciences, Inc. (JBIO)

A side-by-side comparison of Apnimed, Inc. and Jade Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

APMD

Apnimed, Inc.

$808M

$20.28HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT

JBIO

Jade Biosciences, Inc.

$835M

$13.72HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT

Total return — APMD vs JBIO

growth of $100 · dividends reinvested · last 1y

APMD +35.9% (+35.9%/yr)JBIO -27.3% (-27.3%/yr)APMD compounded faster over this window

APMD JBIO

Metrics side by side

Total return (annualized)

Metric	APMD	JBIO
Total return (1Y)	N/A	58.45%
Total return CAGR (3Y)	N/A	-66.83%
Total return CAGR (5Y)	N/A	-52.65%

APMD is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full APMD analysis Full JBIO analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.